Premiere Issue | Fall 2013
|
|
Dear Veterinary Colleague,
|
 Welcome to the premiere edition of West Los Angeles Animal Hospital's newsletter, The Veterinary Reporter. Published quarterly for our friends and colleagues in the veterinary community, The Veterinary Reporter will feature an array of topical articles, interesting case reports, technical training tips, management topics, news, and announcements about our continuing education programs as well as other events. We hope you enjoy our first issue of The Veterinary Reporter and find the content informative and useful in your work. We welcome your comments and suggestions for
future articles that would be of particular interest and helpful
to your practice - just click on the link below to contact us.
I would like to take this opportunity to personally thank you,
as one of our referring primary care veterinarians, for your continuing support and trust in West Los Angeles Animal Hospital. Please know that our entire team's top priority is to continue to earn that trust by providing you and your referred clients and patients with an unparalleled level of expertise, service and compassion. As an extension of your practice, our veterinary specialists work together to provide advanced diagnostics, progressive therapies, and supportive care. From diagnosis to discharge, our goal is to partner with you to provide optimal outcomes for our patients. Please don't hesitate to call us at any time we can be of assistance to you.
David Bruyette, DVM, DACVIM
Medical Director
|
|
Internal Medicine
ENDOCRINOLOGY Part 1: Insulin Update 2013
|
 A number of recent changes have occurred regarding the availability of insulin preparations used in the management of diabetes mellitus in both dogs and cats. In addition, several recent studies have evaluated the use of long-acting basal insulins in patients in the initial management of diabetes as well as the treatment of ketoacidosis. This article summarizes the current state of insulin therapy and how to select the insulin that is best suited for your patients.
|
|
Internal Medicine
ENDOCRINOLOGY Part 2:
Hyperthyroidism in Cats: Diagnosis and Treatment
|
 | "Sir," an 11-year-old Tabby with hyperthyroidism, has been on
the y/d diet for 2 years. |
Hyperthyroidism is recognized as the most common endocrinopathy of older cats. Despite worldwide occurrence, the pathogenesis of feline hyperthyroidism remains unclear. Traditional methods of managing feline hyperthyroidism include thyroidectomy, anti-thyroid medications, and radioactive iodine. Recent studies document that another option now exists for hyperthyroid cats: feeding a limited-iodine food normalizes thyroid hormone concentrations and alleviates clinical signs of hyperthyroidism. Surgery and radioactive iodine are designed to provide permanent solutions, whereas, oral anti-thyroid drugs and nutritional management control hyperthyroidism and are needed daily to achieve/maintain their effect. All management options are effective and each has its pros and cons. It's important to discuss all options with pet owners so the appropriate management can be selected for each hyperthyroid cat.
Read More
|
Case Study
Medical Management of Cushing's Syndrome with Trilostane (Vetoryl)
|
 A 10 year old MC Cocker Spaniel presented for evaluation of severe polyuria and polydipsia (pu/pd) of 3 months duration. Previous laboratory work-up was unremarkable with the exception of a urine specific gravity of 1.010. A CBC and chemistry panel were within normal limits. A urine culture was positive for E. coli and the pet was treated with Baytril (enrofloxacin) at 5 mg/kg once daily for 10 days. No change in the pu/pd was observed. An ACTH stimulation test was performed. The resting cortisol was 2.7 ug/dl with a 1 hour post cortisol of 14.8 ug/dl. These results were considered normal for the laboratory. The patient was referred for additional evaluation of the pu/pd.
Read More
|
Clinical Trials: Call for Cases
West Los Angeles Animal Hospital is currently conducting three clinical studies that our hospital is actively seeking participant cases for from veterinarians. Two of our studies require dogs with rattlesnake bites while the third study calls for newly diagnosed hyperthyroid cats. Following is a brief outline of the trials. For more details about each of the studies, please click on the "Read More" links below.
(1) Thromboelastography (TEG) Study
Thromboelastography (TEG) provides a global assessment of coagulation
status and West Los Angeles Animal Hospital is the only hospital in
Southern California with the capability to evaluate TEG. We are currently
investigating the ability of TEG to predict antivenin needs for dogs that
have been bitten by rattlesnakes. Read More
(2) Efficacy Trial for New Antivenin Product
Patients that require antivenin therapy will be eligible for inclusion in an
efficacy trail for a new antivenin product. Read More
(3) Feline y/d Study
A clinical study to evaluate the safety and efficacy of Hill's Feline y/d in
the management of clinical signs and biochemical abnormalities in cats
with newly diagnosed hyperthyroidism. Read More
Back to Top
|
|
|
JOIN US FOR OUR UPCOMING
CE PROGRAMS!
November 6, 2013
December 4, 2013
January 8, 2014
Click on dates above for details and registration information on our upcoming continuing education programs presented by our specialists in Oncology, Emergency and Critical Care, and Internal Medicine
______________
OUR LOCATION
West Los Angeles
Animal Hospital
1900 S. Sepulveda Blvd.
Los Angeles, CA 90025
Ph 310-473-2951
Fx 310-979-5400
Click on Map for Directions
|
MEET OUR
VETERINARY SPECIALISTS!
Click on Photo
|
|
 |
|
